{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T03:53:50Z","timestamp":1785210830085,"version":"3.55.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,8]],"date-time":"2023-01-08T00:00:00Z","timestamp":1673136000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81974507"],"award-info":[{"award-number":["81974507"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2021M702003"],"award-info":[{"award-number":["2021M702003"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2022QH036"],"award-info":[{"award-number":["ZR2022QH036"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2021A1515110740"],"award-info":[{"award-number":["2021A1515110740"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014103","name":"Key Technology Research and Development Program of Shandong","doi-asserted-by":"publisher","award":["2019JZZY021011"],"award-info":[{"award-number":["2019JZZY021011"]}],"id":[{"id":"10.13039\/100014103","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.apsb.2023.01.003","type":"journal-article","created":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T12:28:31Z","timestamp":1673440111000},"page":"2747-2764","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Discovery of novel sulfonamide substituted indolylarylsulfones as potent HIV-1 inhibitors with better safety profiles"],"prefix":"10.1016","volume":"13","author":[{"given":"Shenghua","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Letian","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusen","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongwei","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mianling","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajie","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2985-8890","authenticated-orcid":false,"given":"Erik","family":"De Clercq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1254-4473","authenticated-orcid":false,"given":"Christophe","family":"Pannecouque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7168-613X","authenticated-orcid":false,"given":"Peng","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4898-7882","authenticated-orcid":false,"given":"Xinyong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2023.01.003_bib1","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.bcp.2012.12.011","article-title":"Antivirals: past, present and future","volume":"85","author":"De Clercq","year":"2013","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.apsb.2023.01.003_bib2","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1126\/science.1206399","article-title":"AIDS. Turning the tide against HIV","volume":"333","author":"Shattock","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.apsb.2023.01.003_bib3","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1021\/acs.chemrev.0c00967","article-title":"Avoiding drug resistance in HIV reverse transcriptase","volume":"121","author":"Cilento","year":"2021","journal-title":"Chem Rev"},{"key":"10.1016\/j.apsb.2023.01.003_bib4","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.apsb.2021.11.009","article-title":"Approved HIV reverse transcriptase inhibitors in the past decade","volume":"12","author":"Li","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2023.01.003_bib5","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.apsb.2019.11.010","article-title":"Development of non-nucleoside reverse transcriptase inhibitors (NNRTIs): our past twenty years","volume":"10","author":"Zhuang","year":"2020","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2023.01.003_bib6","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1517\/14656566.2013.787411","article-title":"Etravirine for the treatment of HIV\/AIDS","volume":"14","author":"Schrijvers","year":"2013","journal-title":"Expet Opin Pharmacother"},{"key":"10.1016\/j.apsb.2023.01.003_bib7","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1080\/14728214.2018.1474202","article-title":"Emerging reverse transcriptase inhibitors for HIV-1 infection","volume":"23","author":"Rai","year":"2018","journal-title":"Expet Opin Emerg Drugs"},{"key":"10.1016\/j.apsb.2023.01.003_bib8","doi-asserted-by":"crossref","first-page":"4065","DOI":"10.2174\/1381612043382404","article-title":"Drug resistance, virus fitness and HIV-1 mutagenesis","volume":"10","author":"Chen","year":"2004","journal-title":"Curr Pharmaceut Des"},{"key":"10.1016\/j.apsb.2023.01.003_bib9","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.3390\/v1031137","article-title":"Mutation rates and intrinsic fidelity of retroviral reverse transcriptases","volume":"1","author":"Men\u00e9ndez-Arias","year":"2009","journal-title":"Viruses"},{"key":"10.1016\/j.apsb.2023.01.003_bib10","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.antiviral.2009.07.006","article-title":"Molecular basis of human immunodeficiency virus drug resistance: an update","volume":"85","author":"Men\u00e9ndez-Arias","year":"2010","journal-title":"Antivir Res"},{"key":"10.1016\/j.apsb.2023.01.003_bib11","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.3390\/cells10071687","article-title":"NNRTI and liver damage: evidence of their association and the mechanisms involved","volume":"10","author":"Benedicto","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.apsb.2023.01.003_bib12","doi-asserted-by":"crossref","DOI":"10.1177\/2040206617753443","article-title":"Indolylarylsulfones, a fascinating story of highly potent human immunodeficiency virus type 1 non-nucleoside reverse transcriptase inhibitors","volume":"26","author":"Famiglini","year":"2018","journal-title":"Antivir Chem Chemother"},{"key":"10.1016\/j.apsb.2023.01.003_bib13","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1021\/jm0211063","article-title":"Novel indolyl aryl sulfones active against HIV-1 carrying NNRTI resistance mutations: synthesis and SAR studies","volume":"46","author":"Silvestri","year":"2003","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2023.01.003_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111619","article-title":"Discovery of novel indolylarylsulfones as potent HIV-1 NNRTIs via structure-guided scaffold morphing","volume":"182","author":"Zhao","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.apsb.2023.01.003_bib15","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ejmech.2016.10.009","article-title":"Discovery of novel piperidine-substituted indolylarylsulfones as potent HIV NNRTIs via structure-guided scaffold morphing and fragment rearrangement","volume":"126","author":"Li","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.apsb.2023.01.003_bib16","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1021\/jm101614j","article-title":"Indolylarylsulfones as HIV-1 non-nucleoside reverse transcriptase inhibitors: new cyclic substituents at indole-2-carboxamide","volume":"54","author":"La Regina","year":"2011","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2023.01.003_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114471","article-title":"Chemical space exploration around indolylarylsulfone scaffold led to a novel class of highly active HIV-1 NNRTIs with spiro structural features","volume":"238","author":"Gao","year":"2022","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.apsb.2023.01.003_bib18","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/0960-894X(95)00059-3","article-title":"2-Heterocyclic indole-3-sulfones as inhibitors of HIV-1 reverse transcriptase","volume":"5","author":"Young","year":"1995","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.apsb.2023.01.003_bib19","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.bmcl.2007.11.085","article-title":"Novel indole-3-sulfonamides as potent HIV non-nucleoside reverse transcriptase inhibitors (NNRTIs)","volume":"18","author":"Zhao","year":"2008","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.apsb.2023.01.003_bib20","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.1021\/acs.jmedchem.1c00268","article-title":"2,4,5-Trisubstituted pyrimidines as potent HIV-1 NNRTIs: rational design, synthesis, activity evaluation, and crystallographic studies","volume":"64","author":"Kang","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2023.01.003_bib21","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.4155\/fmc-2017-0136","article-title":"Routes to drug design via bioisosterism of carboxyl and sulfonamide groups","volume":"9","author":"Arabi","year":"2017","journal-title":"Future Med Chem"},{"key":"10.1016\/j.apsb.2023.01.003_bib22","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1080\/17460441.2022.2044783","article-title":"The importance of sulfur-containing motifs in drug design and discovery","volume":"17","author":"Mustafa","year":"2022","journal-title":"Expet Opin Drug Discov"},{"key":"10.1016\/j.apsb.2023.01.003_bib23","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2174\/1389557043487402","article-title":"Antiviral sulfonamide derivatives","volume":"4","author":"Supuran","year":"2004","journal-title":"Mini Rev Med Chem"},{"key":"10.1016\/j.apsb.2023.01.003_bib24","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.cclet.2014.11.004","article-title":"Identification of the novel N-phenylbenzenesulfonamide derivatives as potent HIV inhibitors","volume":"26","author":"Sun","year":"2015","journal-title":"Chin Chem Lett"},{"key":"10.1016\/j.apsb.2023.01.003_bib25","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.cclet.2019.11.020","article-title":"Fragment-based discovery of sulfur-containing diarylbenzopyrimidines as novel nonnucleoside reverse transcriptase inhibitors","volume":"31","author":"Han","year":"2020","journal-title":"Chin Chem Lett"},{"key":"10.1016\/j.apsb.2023.01.003_bib26","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1080\/13543776.2018.1487400","article-title":"Sulfonamide inhibitors: a patent review 2013-present","volume":"28","author":"Gul\u00e7in","year":"2018","journal-title":"Expert Opin Ther Pat"},{"key":"10.1016\/j.apsb.2023.01.003_bib27","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.2174\/092986708784638898","article-title":"Recent advances in antiviral activity of benzo\/heterothiadiazine dioxide derivatives","volume":"15","author":"Zhan","year":"2008","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.apsb.2023.01.003_bib28","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1021\/acs.jmedchem.0c00015","article-title":"Design, synthesis, and mechanism study of benzenesulfonamide-containing phenylalanine derivatives as novel HIV-1 capsid inhibitors with improved antiviral activities","volume":"63","author":"Sun","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2023.01.003_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112714","article-title":"Discovery and optimization of benzenesulfonamides-based hepatitis B virus capsid modulators via contemporary medicinal chemistry strategies","volume":"206","author":"Ren","year":"2020","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.apsb.2023.01.003_bib30","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1021\/acsmedchemlett.8b00054","article-title":"Further exploring solvent-exposed tolerant regions of allosteric binding pocket for novel HIV-1 NNRTIs discovery","volume":"9","author":"Kang","year":"2018","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.apsb.2023.01.003_bib31","doi-asserted-by":"crossref","first-page":"4837","DOI":"10.1021\/acs.jmedchem.0c00117","article-title":"Structure-based bioisosterism yields HIV-1 NNRTIs with improved drug-resistance profiles and favorable pharmacokinetic properties","volume":"63","author":"Kang","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2023.01.003_bib32","unstructured":"HIV Drug Resistance Database. NNRTI Resistance Notes. Accessed 27 November 2022. Available from: https:\/\/hivdb.stanford.edu\/dr-summary\/resistance-notes\/NNRTI\/."}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383523000035?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383523000035?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T16:57:47Z","timestamp":1761929867000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383523000035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S2211383523000035"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2023.01.003","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of novel sulfonamide substituted indolylarylsulfones as potent HIV-1 inhibitors with better safety profiles","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2023.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}